RT @eyewireplus: .@REGENXBIO announced additional positive interim data from the…
[ad_1]
RT @eyewireplus: .@REGENXBIO announced additional positive interim data from the ongoing phase 2 ALTITUDE trial of RGX-314 for the treatmen…
[ad_2]
Source by Thomas Ciulla, MD, MBA